Champions Oncology Stock Options
| CSBR Stock | USD 9.58 0.56 5.52% |
Champions Oncology's latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 2.07 with a put-to-call open interest ratio of 0.15 over 14 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on May 16th 2025.
Open Interest Against May 16th 2025 Option Contracts
2025-05-16
The chart above shows Champions Oncology's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Champions Oncology's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Champions Oncology's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Champions Oncology
Analyzing Champions Oncology's in-the-money options over time can help investors to take a profitable long position in Champions Oncology regardless of its overall volatility. This is especially true when Champions Oncology's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Champions Oncology's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Champions Oncology's stock while costing only a fraction of its price.
Champions Oncology In The Money Call Balance
When Champions Oncology's strike price is surpassing the current stock price, the option contract against Champions Oncology stock is said to be in the money. When it comes to buying Champions Oncology's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Champions Oncology are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Champions Current Options Market Mood
Champions Oncology's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Champions Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Champions Oncology's options investors are not very successful. Champions Oncology's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Champions contract
Base on the Rule 16, the options market is currently suggesting that Champions Oncology will have an average daily up or down price movement of about 0.13% per day over the life of the 2025-05-16 option contract. With Champions Oncology trading at USD 9.58, that is roughly USD 0.0124. If you think that the market is fully incorporating Champions Oncology's daily price movement you should consider buying Champions Oncology options at the current volatility level of 2.07%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Champions |
Purchasing Champions Oncology options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Champions calls. Remember, the seller must deliver Champions Oncology stock to the call owner when a call is exercised.
Champions Oncology Option Chain
When Champions Oncology's strike price is surpassing the current stock price, the option contract against Champions Oncology stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Champions Oncology's option chain is a display of a range of information that helps investors for ways to trade options on Champions. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Champions. It also shows strike prices and maturity days for a Champions Oncology against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CSBR250516C00017500 | 0 | 17.5 | 0.0 - 5.0 | 5.0 | |
Call | CSBR250516C00015000 | 1 | 15.0 | 0.0 - 1.95 | 0.6 | Out |
Call | CSBR250516C00012500 | 11 | 12.5 | 0.0 - 2.85 | 1.3 | Out |
Call | CSBR250516C00010000 | 95 | 10.0 | 0.0 - 4.9 | 0.85 | Out |
Call | CSBR250516C00007500 | 37 | 7.5 | 0.9 - 5.0 | 2.66 | In |
Call | CSBR250516C00005000 | 67 | 5.0 | 4.4 - 6.9 | 4.0 | In |
Call | CSBR250516C00002500 | 0 | 2.5 | 5.1 - 9.4 | 5.1 | In |
Put | CSBR250516P00017500 | 0 | 17.5 | 5.6 - 10.0 | 5.6 | In |
Put | CSBR250516P00015000 | 0 | 15.0 | 3.3 - 7.5 | 3.3 | In |
Put | CSBR250516P00012500 | 0 | 12.5 | 1.15 - 5.3 | 1.15 | In |
Put | CSBR250516P00010000 | 0 | 10.0 | 0.0 - 4.9 | 4.9 | In |
Put | CSBR250516P00007500 | 20 | 7.5 | 0.1 - 5.0 | 0.5 | Out |
Put | CSBR250516P00005000 | 12 | 5.0 | 0.0 - 5.0 | 1.25 | Out |
Put | CSBR250516P00002500 | 0 | 2.5 | 0.0 - 5.0 | 5.0 |
Champions Oncology Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Champions Oncology Market Cap Over Time
Market Cap |
| Timeline |
Champions Total Stockholder Equity
Total Stockholder Equity |
|
Champions Oncology Corporate Management
| Marianna Zipeto | Research Commercial | Profile | |
| Michael MBA | Chief Officer | Profile | |
| Maria Mancini | Chief Operations | Profile | |
| Karin Heidemann | Executive Operations | Profile | |
| Arthur Hanson | Vice Technology | Profile | |
| BS CMAR | Ex Operations | Profile |
Additional Tools for Champions Stock Analysis
When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.